27 Jun 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Johnson & Johnson (J&J) will open the J&J innovation center in Boston, US, which will be the third of four regional hubs that are being setup in the world's leading life science hotspots. The main objective of the center is to advance healthcare by catalyzing collaborations in science and technology.
The center will house a team of business, science and transaction experts who will be focused on identifying and building novel early-stage collaborations with emerging companies, entrepreneurs and academic centers across eastern North America.
Dr Paul Stoffels, chief scientific officer, Johnson & Johnson, said that, "The East Coast's significance as a hotbed for life sciences innovation grounded in collaboration is indisputable, and continues to grow."
He further added, "With the establishment of our Boston Innovation Center, we look forward to further fostering collaboration with some of the world's leading scientists, renowned academic centers, and influential entrepreneurs to enable future innovations that will advance human health."
Representatives of Johnson & Johnson Development Corporation (JJDC), the venture capital subsidiary of Johnson & Johnson, will also be co-located at the Boston Innovation Center. They will identify and invest in external opportunities.